/ Print /

Tricia Krizner
Regular use of low-dose aspirin may lower breast cancer risk
The medication’s ability to reduce inflammation sited as one possible explanation.
Number of women with metastatic breast cancer rising, as is survival rate
Study highlights the need for services and research for this understudied population.
PARP inhibitor shows promise in ovarian cancer
Study shows Clovis Oncology’s rucaparib shows clinically meaningful impact in delaying disease recurrence in ovarian cancer.
Racial disparity in breast cancer mortality linked to genes
Understanding genetic variations and tumor differences in black women with breast cancer could lead to personalized diagnosis and treatment.
Ovarian cancer: Possible advantage of high blood pressure
New research shows hypertension, diabetes influence survival of ovarian cancer patients in different ways.
Surprising link found in black women breast cancer risk
Alcohol consumption is known to be a risk factor for breast cancer based on studies predominantly done in white women. Now, a University of North Carolina Lineberger Comprehensive Cancer Center study has found the same risk exists for black women.
Asian-American women need better targeted breast cancer therapy
A new study provides new insights into the epidemiology of breast cancer among the most prominent Asian-American ethnic groups in California.
Building the future: The art of strategic planning
How to create your own detailed plan and what every medical practice needs to know about ensuring its future.
Fattening the bottom line by helping patients lose weight
A profile of one practice that successfully added weight loss as an ancillary service.
Ancillary services: The prescription for a difficult business climate
Ancillary services can provide vital revenue enhancements for primary care practices.